Gene Therapy for Liver Metabolic Diseases
Author Information
Author(s): Brunetti-Pierri Nicola
Primary Institution: Baylor College of Medicine
Hypothesis
Can gene replacement therapy provide a definitive cure for inborn errors of liver metabolism?
Conclusion
Gene therapy shows promise as an alternative treatment for liver metabolic diseases, despite existing challenges.
Supporting Evidence
- Gene therapy has shown efficacy in various animal models for liver metabolic diseases.
- Significant morbidity and mortality remain in patients with inborn errors of liver metabolism.
- Gene therapy could potentially provide a long-term solution compared to current treatments.
Takeaway
This study looks at how gene therapy might help fix problems in the liver that some people are born with, which can make them very sick.
Methodology
The article summarizes various gene transfer strategies and their pre-clinical and early clinical results.
Potential Biases
There is a risk of insertional mutagenesis with integrating vectors.
Limitations
The clinical application of gene therapy has been limited by safety concerns and the need for further research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website